DTaP and Tdap Vaccines Market Research Report 2019 ď ľ
Published On : 2 April 2019
E-mail: help@grandresearchstore.com
Report Studies Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for the pertussis-free environment. The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommend all children should be routinely vaccinated for pertussis. According to WHO in 2015, about 86% of infants received three doses of diphtheria-tetanus-pertussis (DTP3) vaccine worldwide to protect them against infectious diseases. E-mail: help@grandresearchstore.com
By Manufacture
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
E-mail: help@grandresearchstore.com
DTaP and Tdap Vaccines Market By Application 6 5 4 3 2 1 0
Application1
Application2 2018
Application3 2025
Application4
growth
E-mail: help@grandresearchstore.com
DTaP and Tdap Vaccines Market Value
CAGR 74.1% (2018 - 2023)
xx
2018
xx
2019
xx
2020
xx
2021
xx
2022
xx
2023
xx
2024
xx
2025
E-mail: help@grandresearchstore.com
Get in touch
+91 8087042414 (Asia)
+1 (646) 781 7170 (International)
www.grandresearchstore.com
help@grandresearchstore.com
Click here to know mor e about report
Follow us: